Side-by-side financials for EVAX and BIIB. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EVAX | BIIB |
|---|---|---|
| Market cap | - | $28.73 B |
| US-listed rank | - | #480 |
| Revenue (latest FY) | - | $9.89B |
| Net income (latest FY) | - | $1.29B |
| Net margin | - | 13.1% |
| P/E (trailing FY) | - | 22.2 |
| SEC filings | 346 | 2,690 |
Full pages: Evaxion Biotech A/S and BIOGEN INC., or browse the full rankings.